Home › Funds › ACT CAPITAL MANAGEMENT, LLC › NUVB
ACT CAPITAL MANAGEMENT, LLC position in NUVB
NUVATION BIO INC · Health Care
ACT CAPITAL MANAGEMENT, LLC reported holding 520,000 shares of NUVB (NUVATION BIO INC) in its Q2 2026 13F filing — a position valued at US$3.0M, representing 1.93% of its reported portfolio and ranking #15 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC has disclosed NUVB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ACT CAPITAL MANAGEMENT, LLC's NUVB position evolved
ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in NUVB in Q4 2025 at 610,500 shares (US$5.5M). Across 3 filings, ACT CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 520,000 shares valued at US$3.0M — an increase of 230,000 shares quarter over quarter.. Notable position changes include a 52% trim in Q1 2026 (shares rose 32% over the following quarter), a 79% increase in Q2 2026 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 610.50K | $5.47M | New |
| Q1 2026 | 290.00K | $1.24M | Reduce |
| Q2 2026 | 520.00K | $2.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 54 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Omega Fund Management, LLC (US$45.9M), Laurion Capital Management LP (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $147.42M · Q2 2026
- Omega Fund Management, LLC 8.08M sh · $45.90M · Q2 2026
- Laurion Capital Management LP 7.82M sh · $44.42M · Q2 2026
- Context Capital Management, LLC 30.00M sh · $31.29M · Q2 2026
- Polar Asset Management Partners Inc. 25.00M sh · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M sh · $25.79M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.74M · Q2 2026
- Redmile Group, LLC 3.03M sh · $17.22M · Q2 2026
- Knoll Capital Management, LLC 1.60M sh · $9.08M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M sh · $7.22M · Q2 2026
- TANAKA CAPITAL MANAGEMENT INC 901.83K sh · $3.87M · Q1 2026
More on ACT CAPITAL MANAGEMENT, LLC
FAQ
How long has ACT CAPITAL MANAGEMENT, LLC held NUVB?
ACT CAPITAL MANAGEMENT, LLC has disclosed NUVB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is ACT CAPITAL MANAGEMENT, LLC's current position in NUVB?
As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 520.00K shares of NUVB (NUVATION BIO INC), valued at $2.95M, representing 1.93% of its reported portfolio and ranking #15.
Has ACT CAPITAL MANAGEMENT, LLC been buying or selling NUVB?
In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC increased its position in NUVB.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Omega Fund Management, LLC, Laurion Capital Management LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.